Print
Quality Positioning System (QPS)
Measure Description Display Information
0377: Hematology: Myelodysplastic Syndrome (MDS) and Acute Leukemias: Baseline Cytogenetic Testing Performed on Bone Marrow
Hematology: Myelodysplastic Syndrome (MDS) and Acute Leukemias: Baseline Cytogenetic Testing Performed on Bone Marrow
STEWARD:
American Society of Hematology
Measure Description:
Percentage of patients aged 18 years and older with a diagnosis of myelodysplastic syndrome (MDS) or an acute leukemia who had baseline cytogenetic testing performed on bone marrow
Numerator Statement:
Patients who had baseline cytogenetic testing performed on bone marrow
Numerator Details:
${NumeratorDetails}
Denominator Statement:
All patients aged 18 years and older with a diagnosis of myelodysplastic syndrome (MDS) or an acute leukemia
Denominator Details:
${DenominatorDetails}
Exclusions:
Documentation of medical reason(s) for not performing baseline cytogenetic testing on bone marrow (eg, no liquid bone marrow or fibrotic marrow)
Documentation of patient reason(s) for not performing baseline cytogenetic testing on bone marrow (eg, at time of diagnosis receiving palliative care or not receiving treatment as defined above)
Documentation of system reason(s) for not performing baseline cytogenetic testing on bone marrow (eg, patient previously treated by another physician at the time cytogenetic testing performed)
Exclusion Details:
${DenominatorExclusionDetails}
Risk Adjustment:
No risk adjustment or risk stratification
Classification:
Measure Type:
Process
Measure Format:
measure
Condition:
Cancer, Hematologic
Non-Condition Specific:
Care Setting:
Outpatient Services
National Quality Strategy Priorities:
Effective Communication and Care Coordination
Current Use:
Planned Use:
Data Source:
Registry Data
Level of Analysis:
Clinician: Group/Practice, Clinician: Individual
Target Population:
Elderly
Measure Steward Contact Information:
For additional measure specification information, please contact the Measure Steward.
Measure Steward Organization:
American Society of Hematology
Primary Measure Steward Contact:
Measure Disclaimer:
Please see the copyright statement above in AD.6 for disclaimer information.
Measure Steward Copyright:
The Measures are not clinical guidelines, do not establish a standard of medical care, and have not been tested for all potential applications.
The Measures, while copyrighted, can be reproduced and distributed, without modification, for noncommercial purposes, e.g., use by health care providers in connection with their practices. Commercial use is defined as the sale, license, or distribution of the Measures for commercial gain, or incorporation of the Measures into a product or service that is sold, licensed or distributed for commercial gain.
Commercial uses of the Measures require a license agreement between the user and the American Medical Association (AMA) or the American Society of Hematology (ASH). Neither ASH, nor the AMA, nor the AMA-convened Physician Consortium for Performance Improvement® (AMA-PCPI), now known as the PCPI, nor their members shall be responsible for any use of the Measures.
The AMA and ASH encourage use of the Measures by other health care professionals, where appropriate.
THE MEASURES AND SPECIFICATIONS ARE PROVIDED “AS IS” WITHOUT WARRANTY OF ANY KIND.
© 2015 American Medical Association and American Society of Hematology. All Rights Reserved.
Limited proprietary coding is contained in the Measure specifications for convenience. Users of the proprietary code sets should obtain all necessary licenses from the owners of these code sets. ASH, the AMA, the PCPI and its members and former members of the AMA-PCPI disclaim all liability for use or accuracy of any Current Procedural Terminology (CPT®) or other coding contained in the specifications.
CPT® contained in the Measures specifications is copyright 2004-2015 American Medical Association. LOINC® copyright 2004-2015 Regenstrief Institute, Inc. SNOMED CLINICAL TERMS (SNOMED CT®) copyright 2004-2015 The International Health Terminology Standards Development Organisation (IHTSDO). ICD-10 is copyright 2015 World Health Organization. All Rights Reserved.
2
0
Status
Most Recent Activity:
Measure Retired and Endorsement Removed Cancer Project 2015-2016
Initial Endorsement:
Jul 31, 2008
Last Endorsement Date:
Oct 26, 2016
Next Planned Maintenance Review:
N/A
Corresponding Measures:
Not Available
View Specifications:
Measure History:
Measure(s) Considered in Harmonization Request
${HarmonizationAssositeMeasures}
NQF Disclaimer:
Measures may be used for non-commercial implementation and/or reporting of performance data. Contact the Measure Steward if you wish to use the measure for another purpose. NQF is not responsible for the application or outcomes of measures.